Terms of Use

Last Updated: February 23, 2018

Please read the following terms and conditions (the “Terms of Use”) carefully before using the www.valneva.us Website and any other web pages or other online services that are owned by Valneva USA Inc. or one of its affiliated corporations (“Valneva” or “us”) and which link to or refer to these Terms of Use (collectively referred to as the “Site“).

THESE TERMS CONTAIN DISCLAIMERS OF WARRANTIES, DISCLAIMERS OF LIABILITY, AND A BINDING ARBITRATION CLAUSE AND CLASS ACTION WAIVER. PLEASE READ THEM CAREFULLY.

IF YOU ARE NOT WILLING TO ACCEPT THESE TERMS OF USE, DO NOT ACCESS OR USE THE WEBSITE OR POST OR SUBMIT ANY MATERIALS ON IT.

Your use of the Site shall be deemed to constitute your agreement to be legally bound by Terms of Use.

“Content” includes, without limitation, messages, information, data, text, software or images, or other content, articles, photographs, images, illustrations, audio clips, video clips and other materials or content available or posted on the Site (collectively, the “Content”).

1. Site Intended Audience

The Site is intended for and directed to residents of the United States. The Site is not intended for anyone under the age of 18.

2. Disclaimers

THE INFORMATION, INCLUDING ANY ADVICE AND RECOMMENDATIONS ON THE WEBSITE, IS INTENDED SOLELY AS A GENERAL EDUCATIONAL AID. IT IS NOT INTENDED AS MEDICAL OR HEALTHCARE ADVICE, OR TO BE USED FOR MEDICAL DIAGNOSIS OR TREATMENT, FOR ANY INDIVIDUAL PROBLEM. IT IS ALSO NOT INTENDED AS A SUBSTITUTE FOR PROFESSIONAL ADVICE AND SERVICES FROM A QUALIFIED HEALTHCARE PROVIDER FAMILIAR WITH YOUR UNIQUE FACTS. ALWAYS SEEK THE ADVICE OF YOUR DOCTOR OR OTHER QUALIFIED HEALTHCARE PROVIDER REGARDING ANY MEDICAL CONDITION AND BEFORE STARTING ANY NEW TREATMENT. YOUR USE OF THE WEBSITE IS SUBJECT TO THE ADDITIONAL DISCLAIMERS AND CAVEATS THAT MAY APPEAR THROUGHOUT THE WEBSITE. WE ASSUME NO RESPONSIBILITY FOR ANY CONSEQUENCE RELATING DIRECTLY OR INDIRECTLY TO ANY ACTION OR INACTION YOU TAKE BASED ON THE INFORMATION, SERVICES, OR OTHER MATERIAL ON THE WEBSITE. WHILE WE STRIVE TO KEEP THE INFORMATION ON THE WEBSITE ACCURATE, COMPLETE, AND UP-TO-DATE, WE DO NOT GIVE ANY ASSURANCES, AND WILL NOT BE RESPONSIBLE FOR, ANY DAMAGE OR LOSS RELATED TO THE ACCURACY, COMPLETENESS, OR TIMELINESS OF THE CONTENT AND INFORMATION ON THE WEBSITE.

Moreover, Valneva does not guarantee nor warrant continuous, uninterrupted or secure access to the Site or to the tools or services provided through the Site. You should be aware the operation of the Site may be interrupted with or without prior warning or notice.

Valneva makes no representations whatsoever about any other website that you may access through the Site, such as where the Site provides a link to another website. A link to a website does not mean that Valneva endorses or accepts any responsibility for the content, practices, or use of such other website.

3. Intellectual Property and Permissible Use

The Site, including without limitation all Content, is protected by U.S. and worldwide copyrights laws and treaty provisions. Any unauthorized copying, redistribution, reproduction or modification of the Content by any person may be a violation of trade-mark and/or copyright laws and could result in legal action. You agree to comply with all applicable copyright laws.

You understand that the Site and the Content are available for your personal, non-commercial use only. You agree that the Site and the Content are the property of Valneva; including all intellectual property rights in them and that you have no right to use them other than as set out in these Terms of Use. We are not responsible for any harm or loss that you suffer in relation to any use you make of the Site for any business purposes or other purposes not authorized under these Terms of Use. We reserve the right to refuse or terminate access to the Site at our discretion. The Site is provided free of charge and we have no obligation to provide any maintenance or support services in relation to them and we are not responsible for any loss or damage you may suffer as a result of any failure to maintain or update the Site.

You may not copy, change or reuse the Site, Content, any updates to them or any part of them including the software incorporated in them, except that you may make use of the Content for your own personal use as follows: you may make one machine readable copy and/or print copy that is limited to occasional articles of personal interest only.

You may use the Site only for lawful purposes and in accordance with these Terms of Use. You are granted a nonexclusive, nontransferable, revocable, limited license to view, print and distribute content retrieved from the Site for your personal, noncommercial purposes, provided that you do not remove or obscure the copyright notice or other notices displayed on the content. You may not copy, reprint, modify, display, perform, translate, distribute, adapt, broadcast, communicate to the public by telecommunication, circulate, or sell the content retrieved from the Site in any way, for any commercial use or provide it to any commercial source, including other websites, without the prior written permission of Valneva.

In addition, you agree not to: (i) use the Site in any manner that could disable, overburden, damage, or impair the Site, or interfere with any other use of the Site, including any user’s ability to engage in real-time activities through the Site; (ii) use any robot, spider or other automatic device, process or means to access the Site for any purpose, including to scrape, data mine, monitor or copy any of the material on the Site; (iii) use any manual process to monitor or copy any of the material on the Site, or to engage in any other unauthorized purpose without the express prior written consent of Valneva; (iv) otherwise use any device, software or routine that interferes with the proper working of the Site; (v) attempt to decipher, decompile, disassemble, or reverse-engineer any of the software comprising or in any way making up a part of the Site; (vi) take any action that violates or threatens our system or network security; (vi) engage in any other conduct that violates any laws; restricts or inhibits any other person from using or enjoying the Site; or otherwise interferes with the proper working of the Site or could harm us or any third party.

We reserve all rights not expressly granted to you.

Notwithstanding rights held by any third party in incorporated elements or software, the Site is an original compilation of independent works and its “look and feel”, including the Content, data, source code or other materials is protected by copyright and is owned or controlled by Valneva and any others which may own copyright or the party credited as the provider of the Content. All visitors shall abide by all copyright notices, information and restrictions contained in any Content.

Any product, process, or technology described in the Site may be subject to other intellectual property rights reserved by Valneva or any third party as the case may be. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent or trademark of Valneva or any third party. Except as provided above, nothing contained herein shall be construed as conferring any license or right under any Valneva or third party copyright.

4. Trademark Notices

The trademarks and brand names displayed on the Site are the property of Valneva, its affiliates or third party owners. You may not use or display any such trademarks or service marks without our prior written consent. You may not use or display any other trademarks or service marks displayed on the Site without the permission of their owners.

5. Electronic Communications

The information communicated on the Site constitutes an electronic communication. When you communicate with us through the Site or via other forms of electronic media, such as e-mail, you are communicating with us electronically. You agree that we may communicate electronically, consistent with applicable law, and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

6. Additional Terms

Additional terms may govern certain features or content on the Site, such as offers, prize draws, competitions, contests and sweepstakes. By participating in any activity on the Site governed by additional terms, such as a prize draw, competition, contest or sweepstakes with Official Rules, you agree that you will be subject to those additional terms in addition to these Terms of Use.

7. Disclaimer of Warranties With Respect to Use of Site

THE SITE IS PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. EXCEPT AS SPECIFICALLY PROVIDED HEREIN, TO THE FULLEST EXTENT PERMISSIBLE PURSUANT TO APPLICABLE LAW, WE EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS, LEGAL OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT.

WE DO NOT MAKE ANY WARRANTY THAT THE SITE WILL MEET YOUR REQUIREMENTS, OR THAT ACCESS TO THESITE WILL BE UNINTERRUPTED, TIMELY, SECURE, OR ERROR-FREE, OR THAT DEFECTS, IF ANY, WILL BE CORRECTED. WE MAKE NO WARRANTIES AS TO THE RESULTS THAT MAY BE OBTAINED FROM THE USE OF THE WEBSITE OR AS TO THE ACCURACY, QUALITY, OR RELIABILITY OF ANY INFORMATION OBTAINED THROUGH THE SITE.

YOU UNDERSTAND AND AGREE THAT ANY MATERIAL AND/OR DATA DOWNLOADED OR OTHERWISE OBTAINED THROUGH THE USE OF THE SITE IS USED AT YOUR OWN RISK AND THAT YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF SUCH MATERIAL AND/OR DATA. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM VALNEVA OR THROUGH THE WEBSITE SHALL CREATE ANY WARRANTY NOT EXPRESSLY MADE HEREIN.

8. Applicable Law and Jurisdiction; Arbitration; Class Action Waiver

The information on the Site is intended only for use by residents of the United States. Other countries may have laws, regulatory requirements, or medical practices that differ from those in United States.

With respect to any and all disputes arising out of or relating to the Site or these Terms of Use (including without limitation the Privacy Policy), Valneva and you agree to negotiate in good faith and undertake reasonable efforts to cooperate with one another in order to achieve a mutually satisfactory resolution. If you and the Valneva do not resolve any dispute by informal negotiation, any other effort to resolve the dispute will be conducted exclusively by binding arbitration as described in this section. You are giving up the right to litigate (or participate in as a party or class member) all disputes in court before a judge or jury. Instead, all disputes will be resolved before a neutral arbitrator, whose decision will be final except for a limited right of appeal under the Federal Arbitration Act. Any court with jurisdiction over the parties may enforce the arbitrator’s award.

YOU FURTHER AGREE THAT ANY PROCEEDINGS TO ARBITRATE OR LITIGATE ANY DISPUTE IN ANY FORUM WILL BE CONDUCTED SOLELY ON AN INDIVIDUAL BASIS. NEITHER YOU NOR VALNEVA WILL SEEK TO HAVE ANY DISPUTE HEARD AS A CLASS ACTION OR IN ANY OTHER PROCEEDING IN WHICH EITHER PARTY ACTS OR PROPOSES TO ACT IN A REPRESENTATIVE CAPACITY. No arbitration or other proceeding will be combined with another without the prior written consent of all parties to all affected arbitrations or proceedings.

Valneva and you agree that all disputes arising under these Terms of Use that cannot be settled through informal negotiation will be settled exclusively through confidential binding arbitration in accordance with the Consumer Arbitration Rules of the American Arbitration Association. The arbitrator’s award shall be binding and may be entered as a judgment in a court of competent jurisdiction. You agree that the Valneva may seek any interim or preliminary relief from a court of competent jurisdiction in New York necessary to protect its rights or property pending the completion of arbitration.

Any claims not subject to arbitration shall be subject to the exclusive jurisdiction of state or federal courts in New York, and you agree to submit to the personal and exclusive jurisdiction of such courts. Use of the Site constitutes consent to the application of those laws, as well as of the following terms and conditions.

9. Limitations of Liability

YOU EXPRESSLY UNDERSTAND AND AGREE THAT UNDER NO CIRCUMSTANCES WILL VALNEVA, ITS AFFILIATES AND ANY OF THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, MANDATARIES OR OTHER REPRESENTATIVES BE LIABLE FOR DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR AGGRAVATED DAMAGES, INCLUDING, WITHOUT LIMITATION, ANY LOSS OF USE, LOSS OF INCOME, SAVING OR PROFITS, LOSS OF DATA, LOSS OF GOODWILL, COST OF PROCUREMENT OF SUBSTITUTE SERVICES, OR ANY OTHER INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, HOWSOEVER CAUSED, AND ON ANY THEORY OF LIABILITY, WHETHER FOR BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE AND STRICT LIABILITY), OR OTHERWISE RESULTING FROM (1) THE USE OF, OR THE INABILITY TO USE, THE WEBSITE; (2) THE COST OF PROCUREMENT OF SUBSTITUTE SERVICES, ITEMS, OR WEBSITES; (3) UNAUTHORIZED ACCESS TO OR ALTERATION OF YOUR TRANSMISSIONS OR DATA (INCLUDING PERSONAL INFORMATION); (4) THE STATEMENTS OR CONDUCT OF ANY THIRD PARTY ON THE WEBSITE; OR (5) ANY OTHER MATTER RELATING TO THE WEBSITE. THESE LIMITATIONS WILL APPLY WHETHER OR NOT VALNEVA HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. THIS EXCLUSION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAWS. ANY CLAIM AGAINST US SHALL BE LIMITED TO THE AMOUNT YOU PAID, IF ANY, FOR THE USE OF THE SERVICES.

10. Modification or Suspension of the Site

We will make reasonable efforts to make the Site available but we may from time to time need to interrupt, restrict, modify or discontinue, temporarily or permanently the Site or parts of it without notice. We will not be responsible for any harm or loss you may suffer as a result of such actions.

11. Termination

We may at any time terminate your use of or access to the Site and may delete any or all of your User Content without prior notice if we have a good reason to do so which includes any breach by you of these Terms of Use and the Community Guidelines. We will not be responsible for any loss or harm you may suffer as a result of termination of your use of the Site in these circumstances.

12. Links to Third Party Sites

The Site may contain links or references to third party websites. These links are provided for your convenience only. No endorsement of any third party products, services or information is expressed or implied by any information, material or content of any third party contained in, referred to, included on, or linked from or to the Site. Any information, data, opinions, recommendations, products or services provided by such third parties through links to other websites or otherwise made available through their websites are solely those of such third parties and not of Valneva. Your use of such third party websites is subject to the terms of use and the privacy policies of such websites.

13. Indemnification

You agree to indemnify and hold harmless Valneva and its affiliates and their respective directors, officers, employees, agents, or other representatives from and against all claims, liability, damages and expenses, including without limitation all legal fees and costs arising from or relating to (a) your breach of these Terms of Use; (b) your use of the Site including without limitation transmission or placement of information or material by you on the Site; and (c) any claim or allegation that any of your User Content infringes the intellectual property or other proprietary rights, or privacy rights, of any third party.

14. Modifications to these Terms

We may make changes to the Terms of Use from time to time in our sole discretion, by updating these Terms of Use on the Site, and specifying the effective date of the new version of the Terms of Use. The “Last Modified” date at the top of these Terms of Use will indicate when the latest changes were made. Your continued use of the Site following the posting of a new version of the Terms of Use constitutes your acceptance of any such changes. Accordingly, whenever you visit the Site, you should check to see if a new version of the Agreement has been posted.

15. Contact Information

If you have any questions or concerns with respect to these Terms of Use or the Site you may contact us as identified in the Privacy Policy or the “Contact Us” section of the Site.

16. Severability

Should any part or provision of these Terms of Use be held unlawful, void, invalid, or unenforceable that portion shall be deemed severable from these Terms of Use and shall not affect the validity and enforceability of any remaining provisions.

17. Survival

All Sections shall survive the termination of the right to use the Site.

Risk areas and transmission season for Japanese encephalitis (JE), by country^*,†,‡

Country	Affected areas	Transmission season	Comments
Australia	Outer Torres Strait Islands, northern Cape York	December–May; all human cases reported February–April	Rare cases reported from Outer Torres Strait Islands and 1 case previously reported from northern Queensland mainland Vaccine only recommended for Outer Torres Strait Islands
Bangladesh	Widespread	Year-round with most cases reported May–November	Cases reported from multiple areas, including Chittagong, Dhaka, Khulna, Rajshahi, Ranjpur, and Sylhet Divisions, so transmission likely countrywide
Bhutan	Presumed transmission in nonmountainous areas	Unknown	Rare cases reported but limited data Proximity to endemic areas of India and presence of vectors suggests transmission likely
Brunei Darussalam	Presumed widespread	Unknown	Limited data but outbreak reported in 2013 Proximity to Sarawak, Malaysia suggests ongoing transmission likely
Burma (Myanmar)	Presumed widespread	Year-round with most cases reported July–September
Cambodia	Widespread	Year-round with peak season May–October	Cases reported from majority of provinces, so transmission likely countrywide
China	All provinces except Xinjiang and Qinghai	Peak season June–October
India	Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Goa, Haryana, Jharkhand, Karnataka, Kerala, Maharashtra, Manipur, Meghalaya, Nagaland, Odisha, Punjab, Tamil Nadu, Telangana, Tripura, Uttar Pradesh, Uttarakhand, West Bengal	Peak season May–November, especially in northern India; the season may be extended or yearround in some areas, especially in southern India
Indonesia	Widespread	Year-round, with peak season varying by island	Cases reported from many islands, including Sumatra, Java, Kalimantan, Bali, Nusa Tenggara, and Papua, so transmission likely on all islands Several traveler cases reported in recent years from Bali
Japan	All islands	June–October	Rare sporadic cases reported from all islands except Hokkaido Enzootic transmission without reported human cases on Hokkaido
Lao People’s Democratic Republic	Widespread	Year-round with peak season June–September
Malaysia	Widespread	Year-round, with peak season in Sarawak from October–December	Much higher rates of disease reported from Sarawak than peninsular Malaysia
Nepal	Southern lowlands (Terai), some hill and mountain districts	Peak season June–October	Highest rates of disease reported from southern lowlands (Terai) Vaccine not routinely recommended for those trekking in high-altitude areas
North Korea	Presumed widespread	Unknown Proximity to South Korea suggests peak transmission May–November
Pakistan	Unknown	Unknown	Very limited data Rare cases reported from Sindh Province
Papua New Guinea	Widespread	Presumed year-round	Sporadic cases reported from Western Province, serologic evidence of disease from Gulf and Southern Highland Provinces, and 1 case reported from near Port Moresby, so transmission likely countrywide
Philippines	Widespread	Year-round with peak season April–August	Human, animal, and mosquito studies have indicated transmission in 32 provinces, so transmission likely on all islands
Russia	Primorsky Krai	June–September	Cases previously reported from Primorsky Krai Vaccine not routinely recommended
Singapore	Presumed in focal areas	Year-round	Very rare sporadic cases reported Vaccine not routinely recommended
South Korea	Widespread	May–November
Sri Lanka	Widespread except in mountainous areas	Year-round with peak season November–February
Taiwan	Widespread	Peak season May–October
Thailand	Widespread	Year-round with peak season May–October, especially in northern Thailand	Highest rates of disease reported from Chiang Mai Valley Several traveler cases reported in recent years from resort and coastal areas of southern Thailand
Timor-Leste	Presumed widespread	No data Proximity to West Timor suggests year-round
Viet Nam	Widespread	Year-round with peak season May–October, especially in northern Viet Nam

^*Destination and transmission season information should be considered in association with travel duration and activities when making decisions on vaccination.

^†Data are based on published and unpublished reports. Risk assessments should be performed cautiously, because risk can vary within areas and from year to year, and surveillance data regarding human cases and JE virus transmission are often incomplete. In some endemic areas, human cases among residents are limited because of vaccination or natural immunity among older people. However, because JE virus is maintained in an enzootic cycle between animals and mosquitoes, susceptible visitors to these areas still may be at risk for infection.

^‡Outbreaks previously occurred in the Western Pacific Islands of Guam (1947–1948) and Saipan (1990), but as they are no longer considered risk areas, they are not included in the table.

Privacy Declaration

Last Updated: 01. May 2019

Valneva SE and its affiliates (“Valneva“,“we“, “us” or “our“) have created this privacy declaration (hereafter referred to as the “Privacy Declaration“) in order to demonstrate our firm commitment to privacy. The following discloses our processing of personal data (Article 4/1 Regulation (EU) 2016/679, “GDPR”) with regard to the use of our websites as well as with regard to our customers, pharmacovigilance, vendors and persons applying for a job at Valneva.

This Privacy Policy applies to individuals we deal with including consumers, patients, health care professionals and others within the health care or pharmaceutical industries (“you” or “your“), and explains how we collect, use, disclose and otherwise process and protect your Personal Data. This Privacy Policy further includes a description of your data privacy rights as a data subject.

1. Use of the Websites

With using our websites www.valneva.com, www.valneva.at, www.valneva.se, www.valnevauk.com, www.valneva.us, www.valneva.ca, www.preventje.com and the sub-sites under the listed domains you accept that we collect and process data regarding your behaviour on our website.

This processing is based on your consent being given by the usage of this website.

The Site may collect information from visitors both by asking you specific questions and by permitting you to communicate directly with us via email and/or feedback forms. Some of the information that you submit on the Site may be Personal Data. A site may further use “cookies” and Internet Protocol (“IP”) addresses. A cookie is a bit of information that a website sends to your web browser that helps the site remember information about you and your preferences and an IP address is a number assigned to your computer by your Internet service provider. The IP address can be used to diagnose problems with a server, report aggregate information, determine the fastest route for your computer to use in connecting to a site, and administer and improve the site. Please read more here: https://www.valneva.com/en/legal/cookie-policy

Please note that if you wish to subscribe and connect your personal social media account to our Site, e.g. if you would like to share information on your own social media account, certain Personal Data will be shared with us such as Personal Data linked to your profile or your friends profiles on the applicable social media account.

2. Pharmacovigilance

Pharmacovigilance is the process of discovering, evaluating, understanding and preventing adverse reactions or other problems related to medicines. Their notification is of great importance for public health. We will only use and share this information for pharmacovigilance purposes. This processing is necessary for compliance with a legal obligation to which Valneva is subject.

Valneva is required to store and report information relevant to pharmacovigilance to health authorities worldwide (including countries whose data protection levels differ from those of the EU). The reports contain detailed information on the incident, but only to a limited extent personal data.

With regard to patients, the notification will contain, if available, only age, date of birth, year of birth, gender and initials, depending on the information available, but never the name of the patient.

With regard to the notifier, the notification will include, depending on the information available, the name, professional activity (e.g. doctor, pharmacist), address, e-mail address and telephone number. The contact details are necessary to be able to follow up the reporting and thus obtain high-quality and complete information on adverse events.

Information on notifications will be kept for at least ten (10) years after the product is no longer on the market in any country.

3. Recruitment:

We will store and process your data for the purpose of your application based on your consent and based on Article 6/1 lit b General Data Protection Regulation. We will forward your personal data and the attachments you provided to the respective country organization with applicable open job opportunities. We will keep your personal data in evidence for filling additional positions for a maximum period of seven months from the date of the receipt of your application.

Your data will be kept strictly confidential, will not be passed on to any other companies except Valneva country organizations with applicable open job opportunities and will only be passed on within the company to the heads of departments where a suitable position is available.

Your data will be deleted automatically after seven (7) months from the date of receipt of your application. You can revoke your consent to data processing at any time in writing via gdpr@valneva.com. In this case please refer to your job application and we will delete your personal data.

4. Vendor, customer or other business partners:

We will not use your personal data for marketing activities unless you have consented to receive marketing communications from us.

Based either on consent or, when applicable, on the fulfilment of contractual obligations, we will store your name, contact details and your position within your company being a vendor, customer or other business partner.

Based on your consent, we will publish your data as a health care professional on our website www.reisemedizincheck.at (for Austria) or www.bewareofthebugs.com (for United Kingdom).

5. Medical Requests:

Your medical requests regarding our products will be stored due to legal obligations and in the legitimate interests of Valneva to have evidence about the information provided when replying to medical requests. We will store your name, contact details, content of your request and content of our reply to your request.

We will store this data for a period of 30 years after having received your medical request.

6. Security

We take reasonable steps to protect your Personal Data using physical (locked filing cabinets and restricted access to offices), electronic (especially firewalls) or procedural security measures appropriate to the sensitivity of the information. Valneva will take appropriate steps to ensure that Personal Data about you is protected from loss or theft, as well as unauthorised access, disclosure, copying, use or modification.

Although we have enacted security measures, we cannot guarantee the security of any information that you submit via email or over the Internet. To the extent permitted under applicable law, we make no warranty, express or implied, concerning the security or integrity of any Personal Data. You submit your Personal Data using such networks at your own risk, since no Internet transmission is ever 100% secure or error-free (in particular, emails sent to or from the Site may not be secure). You should take special care in deciding what information you send to us via email or posting on the Site. Moreover, where you use passwords, ID numbers or other special access features on the Site, it is your responsibility to safeguard them.

7. Links to other Websites

The Site may contain links or references to other websites to which this Privacy Policy does not apply. Valneva is not responsible for the data collection and use practices of companies or organisations to which the Site may provide links. We encourage you to read the privacy statement/policy of every website you visit.

Valneva makes no representations whatsoever about any other website which you may access through this Site. In addition, a link to a website does not mean that Valneva endorses or accepts any responsibility for the content, or the use, of such website

8. Collection of Personal Data from Children

This Site is not directed to individuals under the age of sixteen (16) (or such other lower age determined by applicable laws), and we do not knowingly collect any Personal Data from children under such age.

Should we need to process Personal Data of an individual under the age of sixteen (16) (or such other lower age determined by applicable laws) consent to such processing must be given by an authorized person with parental responsibility for the child.

9. Privacy Policy Changes

This Privacy Policy may be revised from time to time. If we intend to use or disclose Personal Data for purposes materially different than those described in this Privacy Policy, we will make reasonable efforts to notify affected individuals, if necessary, including by posting the revised Privacy Policy on this Site. We recommend that you review this Privacy Policy frequently.

10. Information Regarding Your Rights

If you would like to access your Personal Data or get it rectified, updated, erased or transferred to other organizations please contact us at the address below. You also have the right to object or to restrict some processing and, where we have asked for your consent to process your Personal Data, to withdraw your consent at any time and we will stop any future use of your Personal Data (unless there is a legitimate interest that prevents us from doing so). We may request a reasonable fee for administering certain requests. Authorised employees, agents and representatives of Valneva who require access to your Personal Data in order to fulfil their job requirements will have access to your Personal Data.

You may contact us by writing to us at the following address:

Valneva Austria GmbH, Campus Vienna Biocenter 3, A-1030 Vienna, Austria

You may also contact Valneva`s Data Protection Officer at:

gdpr@valneva.com

NOTE: If you are a physician or other health care professional and would like to record an adverse event, please contact safety@valneva.com

11. Contact the Supervisory Authority

If you have any comments or complaints regarding the way your Personal Data is being handled, you have the right to contact the supervisory authority in your country of residence to lodge a complaint. Please click here to obtain relevant contact information to supervisory authorities: http://ec.europa.eu/justice/article-29/structure/data-protection-authorities/index_en.htm

I confirm that I am a US healthcare professional.

I confirm that I am a US resident.

I confirm that I am a US healthcare professional.

Do you or a member of your family work for the U.S. Department of Defense?

I am a Canadian healthcare professional.

I am a Canadian resident.

I confirm that I am a US resident.

JE Checklist for Travel to Asia

Assess Risk of JE Virus Exposure

Destination, duration, activities

Barrier Protection & Mosquito Avoidance⁸

Insect repellent
Bed nets
Aerosol room insecticides
Minimize outdoor and evening activity

The 4 Os of Je Vaccination^8,9

Give IXIARO®

For travel in endemic areas:

ONE (1) MONTH

Consider
IXIARO®

For travel less than 1 month:

OUTDOORS:

Substantial time outdoors
Extensive outdoor activities
Spending time outdoors at night
Time in rural or agricultural areas
Accommodation without air conditioning, screens, or bed nets

OTHER PLANS:

Uncertain destinations
Uncertain activities
Uncertain travel duration

OUTBREAKS:

Traveling during a JE outbreak

JE Checklist for Travel to Asia

Assess Risk of JE Virus Exposure

Destination, duration, activities

Barrier Protection & Mosquito Avoidance⁸

Insect repellent
Bed nets
Aerosol room insecticides
Minimize outdoor and evening activity

The 4 Os of Je Vaccination^8,9

Give IXIARO®

For travel in endemic areas:

ONE (1) MONTH

Consider
IXIARO®

For travel less than 1 month:

OUTDOORS:

Substantial time outdoors
Extensive outdoor activities
Spending time outdoors at night
Time in rural or agricultural areas
Accommodation without air conditioning, screens, or bed nets

OTHER PLANS:

Uncertain destinations
Uncertain activities
Uncertain travel duration

OUTBREAKS:

Traveling during a JE outbreak

Risk for Japanese Encephalitis by Country^4*

Country	Affected areas	Transmission season
Australia	Outer Torres Strait islands	December–May; all human cases reported February–April
Bangladesh	Presumed widespread	Most human cases reported May–October
Bhutan	Very rare reports; probably endemic in nonmountainous areas	No data
Brunei	Very rare reports; presumed to be endemic countrywide	Unknown; presumed year round
Burma (Myanmar)	Limited data; presumed to be endemic countrywide	Unknown; most human cases reported May–October
Cambodia	Presumed to be endemic countrywide	Year round; peak season May–October
China	Human cases reported from all provinces except Xizang (Tibet), Xinjiang and Qinghai.	Most human cases reported June–October
East Timor	Sporadic human cases reported; presumed to be endemic countrywide	No data; cases reported year round in neighboring West Timor
India	Human cases reported from all states except Dadra, Daman, Diu, Gujarat, Himachal Pradesh, Jammu and Kashmir, Lakshadweep, Meghalaya, Nagar Haveli, Punjab, Rajasthan and Sikkim	Most human cases reported May–October, especially in northern India; the season may be extended or year round in some areas, be extended or year round in some areas, especially in southern India
Indonesia	Presumed to be endemic countrywide	Year round; peak season varies by island
Japan**	Rare sporadic human cases on all islands except Hokkaido; enzootic activity ongoing	Most human cases reported July–October
Korea, North	Limited data; presumed to be endemic countrywide	No data; proximity to South Korea suggests peak transmission is likely to be May–October
Korea, South**	Rare sporadic human cases countrywide; enzootic activity ongoing	Most human cases reported May–October
Laos	Limited data; presumed to be endemic countrywide	Year round; peak season June–September
Malaysia	Endemic in Sarawak; sporadic cases reported from all other states; occasional outbreaks reported	Year round; in Sarawak, peak season October–December
Nepal	Endemic in southern Iowlands (Terai); cases also reported from hill and montain districts, including the Kathmandu valley	Most human cases reported June-October
Pakistan	Limited data; human cases reported from around Karachi	Unknown
Papua New Guinea	Limited data; probably widespread	Unknown; probably year round
Philippines	Limited data; presumed to be endemic on all islands	Year round; peak season June–September
Russia	Rare human cases reported from the Far Eastern maritime areas south of Khabarovsk	Most human cases reported July–September
Singapore	Rare sporadic human cases reported	Year round
Sri Lanka	Endemic countrywide except in mountainous areas	Year round; variable peaks based on monsoon rains
Taiwan^**	Rare sporadic human cases islandwide	Most human cases reported May–October
Thailand	Endemic countrywide; seasonal epidemics in the northern provinces	Year round; peak season May–October, provinces especially in the north
Vietnam	Endemic countrywide; seasonal epidemics in the northern provinces	Year round; peak season May–October, especially in the north
Western Pacific Islands	Outbreaks of human disease reported in Guam in 1947–1948 and Saipan in 1990	Unknown; most human cases reported October–March
*Data are based on published reports and personal correspondence. Risk assessments should be performed cautiously, because risk can vary within areas and from year to year, and surveillance data regarding human cases and JE virus transmission are incomplete.
**In some endemic areas, human cases among residents are limited because of natural immunity among older people or vaccination. However, because JE virus is maintained in an enzootic cycle between animalsand mosquitoes, susceptible visitors to these areas still may be at risk of infection.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Progression of JE

Select Stage to Learn More

5-15 Days^4,7

• Fever

• Diarrhea

• Headache

• Myalgia

• Nausea and Vomiting

• Acute encephalopathy

• Change in mental status

• Mild confusion to agitation to coma

• Parkinsonian syndrome

• Upper and lower motor neuron paralysis

• Seizures

Gradual recovery or
Persistence of CNS signs

• Severe Cognitive and memory impairments

• Psychiatric and behavioral disturbances

• Neuromuscular dysfunction

• Impairment of activities of daily living (ADLs)

• Seizures

Risk areas and transmission season for Japanese encephalitis (JE), by country^*,†,‡

JE Checklist for Travel to Asia

Assess Risk of JE Virus Exposure

Barrier Protection & Mosquito Avoidance⁸

The 4 Os of Je Vaccination^8,9

JE Checklist for Travel to Asia

Assess Risk of JE Virus Exposure

Barrier Protection & Mosquito Avoidance⁸

The 4 Os of Je Vaccination^8,9

Progression of JE

Select Stage to Learn More

5-15 Days4,7

• Fever

• Diarrhea

• Headache

• Myalgia

• Nausea and Vomiting

• Acute encephalopathy

• Change in mental status

• Mild confusion to agitation to coma

• Parkinsonian syndrome

• Upper and lower motor neuron paralysis

• Seizures

Gradual recovery or Persistence of CNS signs

• Severe Cognitive and memory impairments

• Psychiatric and behavioral disturbances

• Neuromuscular dysfunction

• Impairment of activities of daily living (ADLs)

• Seizures

5-15 Days^4,7

Gradual recovery or
Persistence of CNS signs